解码外体秘密组:干细胞选择的微环境重编程用于前十字带再生医学
Junjie Chen1,2, Jiayang He3, Dujiang Yang4
1Department of Rehabilitation, Jinniu District People's Hospital of Chengdu, Chengdu, China.
Frontiers in bioengineering and biotechnology
|December 15, 2025
概括
来自干细胞的外体细胞显示出改善前十字带 (ACL) 破裂修复的潜力,通过解决炎症和不良移植整合等挑战. 本综述评估了它们对ACL重建结果的治疗潜力.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 整形外科手术 整形外科手术
背景情况:
- 前交叉带 (ACL) 破裂是一种常见的残疾伤害,需要手术重建.
- 目前的ACL重建结果通常由于炎症,痕组织和肌骨愈合不良而不足.
- 干细胞疗法具有潜力,但面临着瘤发生等安全问题.
研究的目的:
- 系统地审查干细胞衍生的外体的治疗潜力,用于ACL破裂修复.
- 评估阻碍ACL移植整合的关键因素的外体介导调制.
主要方法:
- 在ACL破裂修复模型中研究干细胞衍生外体的研究的系统文献综述.
- 在ACL愈合的背景下,对免疫反应,新血管化,痕形成和骨质稳态的外体效应的分析.
主要成果:
- 外体体表现出对ACL修复有益的免疫调节特性.
- 外体促进新血管和影响痕组织的形成.
- 外体调节骨稳态,可能改善肌骨的愈合.
结论:
- 来自干细胞的外体体是一种有前途的无细胞治疗策略,用于增强ACL破裂修复.
- 外体细胞可以克服传统干细胞治疗的局限性,并改善ACL重建中的手术结果.
相关概念视频
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K


